Work

Glycine transporter 1 is a target for the treatment of epilepsy

Year: 2015

Type: article

Source: Neuropharmacology

DOI: 10.1016/j.neuropharm.2015.08.031

Authors: Hai-Ying Shen, Erwin A. van Vliet, Kerry-Ann Bright, Marissa Hanthorn, Nikki K. Lytle, Jan Gorter, Eleonora Aronica, Detlev Boison

Institutions: Legacy Health, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Stichting Epilepsie Instellingen Nederland

Language: English

Topic: Epilepsy research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Johns Hopkins University, National Institute of Neurological Disorders and Stroke

Awards: Glycine augmentation therapy for the treatment of epilepsy, Ketogenic Diet and Adenosine: Epigenetics and Antiepileptogenesis

OpenAlex ID: W1201902931

FWCI: 4.327

Cites: 86

Cited by: 54

Related to: 10